Show simple item record

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).

dc.contributor.authorLyon, ARen_US
dc.contributor.authorLópez-Fernández, Ten_US
dc.contributor.authorCouch, LSen_US
dc.contributor.authorAsteggiano, Ren_US
dc.contributor.authorAznar, MCen_US
dc.contributor.authorBergler-Klein, Jen_US
dc.contributor.authorBoriani, Gen_US
dc.contributor.authorCardinale, Den_US
dc.contributor.authorCordoba, Ren_US
dc.contributor.authorCosyns, Ben_US
dc.contributor.authorCutter, DJen_US
dc.contributor.authorde Azambuja, Een_US
dc.contributor.authorde Boer, RAen_US
dc.contributor.authorDent, SFen_US
dc.contributor.authorFarmakis, Den_US
dc.contributor.authorGevaert, SAen_US
dc.contributor.authorGorog, DAen_US
dc.contributor.authorHerrmann, Jen_US
dc.contributor.authorLenihan, Den_US
dc.contributor.authorMoslehi, Jen_US
dc.contributor.authorMoura, Ben_US
dc.contributor.authorSalinger, SSen_US
dc.contributor.authorStephens, Ren_US
dc.contributor.authorSuter, TMen_US
dc.contributor.authorSzmit, Sen_US
dc.contributor.authorTamargo, Jen_US
dc.contributor.authorThavendiranathan, Pen_US
dc.contributor.authorTocchetti, CGen_US
dc.contributor.authorvan der Meer, Pen_US
dc.contributor.authorvan der Pal, HJHen_US
dc.contributor.authorESC Scientific Document Groupen_US
dc.date.accessioned2023-05-04T09:24:32Z
dc.date.issued2022-11-01en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/86171
dc.format.extent4229 - 4361en_US
dc.languageengen_US
dc.relation.ispartofEur Heart Jen_US
dc.subjectAmyloid light-chain cardiac amyloidosisen_US
dc.subjectAndrogen deprivation therapyen_US
dc.subjectAnthracyclineen_US
dc.subjectArrhythmiasen_US
dc.subjectAtrial fibrillationen_US
dc.subjectBiomarkersen_US
dc.subjectCanceren_US
dc.subjectCancer survivorsen_US
dc.subjectCarcinoid syndromeen_US
dc.subjectCardiac magnetic resonanceen_US
dc.subjectCardiac tumouren_US
dc.subjectCardio-oncologyen_US
dc.subjectCardiotoxicityen_US
dc.subjectChemotherapyen_US
dc.subjectCoronary artery diseaseen_US
dc.subjectEchocardiographyen_US
dc.subjectFluoropyrimidineen_US
dc.subjectGuidelinesen_US
dc.subjectHaematopoietic stem cell transplantationen_US
dc.subjectHeart failureen_US
dc.subjectHormone therapyen_US
dc.subjectHypertensionen_US
dc.subjectImmunotherapyen_US
dc.subjectIschaemic heart diseaseen_US
dc.subjectMyocarditisen_US
dc.subjectPericardial diseaseen_US
dc.subjectProteasome inhibitorsen_US
dc.subjectPulmonary hypertensionen_US
dc.subjectQTc prolongationen_US
dc.subjectRadiotherapyen_US
dc.subjectRisk stratificationen_US
dc.subjectStrainen_US
dc.subjectThrombosisen_US
dc.subjectTrastuzumaben_US
dc.subjectValvular heart diseaseen_US
dc.subjectVascular endothelial growth factor inhibitors (VEGFi)en_US
dc.subjectVenous thromboembolismen_US
dc.subjectHumansen_US
dc.subjectRadiation Oncologyen_US
dc.subjectMedical Oncologyen_US
dc.subjectNeoplasmsen_US
dc.subjectHearten_US
dc.subjectHematologyen_US
dc.subjectAntineoplastic Agentsen_US
dc.title2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).en_US
dc.typeArticle
dc.identifier.doi10.1093/eurheartj/ehac244en_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/36017568en_US
pubs.issue41en_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume43en_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record